Therapeutically exploiting STAT3 activity in cancer—using tissue repair as a road map

J Huynh, A Chand, D Gough, M Ernst - Nature Reviews Cancer, 2019 - nature.com
The tightly orchestrated temporal and spatial control of signal transducer and activator of
transcription 3 (STAT3) activity in epithelial, immune and stromal cells is critical for wound …

Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation

J Dong, XD Cheng, WD Zhang… - Journal of Medicinal …, 2021 - ACS Publications
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that
regulates various biological processes, including proliferation, metastasis, angiogenesis …

Acute myeloid leukemia: a comprehensive review and 2016 update

I De Kouchkovsky, M Abdul-Hay - Blood cancer journal, 2016 - nature.com
Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an
incidence of over 20 000 cases per year in the United States alone. Large chromosomal …

[HTML][HTML] Highlighted STAT3 as a potential drug target for cancer therapy

H Lee, AJ Jeong, SK Ye - BMB reports, 2019 - ncbi.nlm.nih.gov
Signal transducer and activator of transcription 3 (STAT3) is a cytoplasmic transcription
factor that regulates cell proliferation, differentiation, apoptosis, angiogenesis, inflammation …

Mechanisms of muscle wasting in chronic kidney disease

XH Wang, WE Mitch - Nature Reviews Nephrology, 2014 - nature.com
In patients with chronic kidney disease (CKD), loss of cellular proteins increases the risks of
morbidity and mortality. Persistence of muscle protein catabolism in CKD results in striking …

Targeting the JAK/STAT signaling pathway using phytocompounds for cancer prevention and therapy

S Bose, S Banerjee, A Mondal, U Chakraborty… - Cells, 2020 - mdpi.com
Cancer is a prevalent cause of mortality around the world. Aberrated activation of Janus
kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway …

The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation

ML Amaya, A Inguva, S Pei, C Jones… - Blood, The Journal …, 2022 - ashpublications.org
Acute myeloid leukemia (AML) is characterized by the presence of leukemia stem cells
(LSCs), and failure to fully eradicate this population contributes to disease …

Targeting the interleukin-6/Jak/stat pathway in human malignancies

P Sansone, J Bromberg - Journal of Clinical Oncology, 2012 - ascopubs.org
The Janus kinase/signal transducer and activator of transcription (Jak/Stat) pathway was
discovered 20 years ago as a mediator of cytokine signaling. Since this time, more than …

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia

MH Kramer, Q Zhang, R Sprung, RB Day… - Blood, The Journal …, 2022 - ashpublications.org
We have developed a deep-scale proteome and phosphoproteome database from 44
representative acute myeloid leukemia (AML) patients from the LAML TCGA dataset and 6 …

The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer

SW Wang, YM Sun - International journal of oncology, 2014 - spandidos-publications.com
Among the cytokines linked to inflammation-associated cancer, interleukin (IL)-6 drives
many of the cancer 'hallmarks' through downstream activation of the Janus kinase/signal …